Transgene Biotek Limited

₹2.54As of Sun 8 Nov 2026, 12:00 UTC
BSE:526139Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (0.97%)
Div yield —
ROE (17.96%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.98
PE TTM —
TSR TTM (32.80%)
Mkt cap ₹192.5M
ROIC (2.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹3.19
25.74%
254.89%
Hold 10|11|8|4|0
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.03
0.03
0.03
0.03
10.09%
6.78%
1.77%
0.84%
Revenue₹M
10.47
10.21
10.26
10.69
7.11%
4.82%
4.94%
6.55%
Peers (US$2.009M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.765
0.156
0.155
EBIT/Intx
0.117
0.323
0.387
Own earn%
(21.43)
203.98
132.13
Sh yield%
36.55
26.92
27.62
Owners
Insiders/Inst%
3.60
84.76
Short interest%
2.07
SBC / revenue%
5.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
9–13
$1 testx
0.0
Incr. ROIC%
5